What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
about
Emerging preclinical pharmacological targets for Parkinson's diseaseSerotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's DiseaseThe role of Galectin-3 in α-synuclein-induced microglial activation.Acceleration of α-synuclein aggregation by exosomes.Chronic exposure to cerebrospinal fluid of multiple system atrophy in neuroblastoma and glioblastoma cells induces cytotoxicity via ER stress and autophagy activationHigh pressure promotes alpha-synuclein aggregation in cultured neuronal cells.Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.Animal models of Parkinson's disease: a gateway to therapeutics?Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents.Is Parkinson's disease truly a prion-like disorder? An appraisal of current evidence.Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein.Incidence and prevalence of Parkinson's disease among Navajo people living in the Navajo nation.Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity.Pesticides and Parkinson's disease: is it in your genes?Patterns of Tau and α-Synuclein Pathology in the Visual System.Chem/bio sensing with non-classical light and integrated photonics.
P2860
Q26764724-196FB068-90F9-4FBA-AE1A-65D6105A6A7FQ28079379-470F9AEE-C5C2-4783-8DBD-AF2CBDB60600Q34537231-841D3F60-7B5B-44DE-89CB-0C1C292E08B3Q35048929-2B679C80-9AF8-44FA-B27D-DEA2D33B5168Q35955278-BD0D748D-4797-43B1-AE80-4B1E6704658EQ36322512-2FE67C18-D267-4203-9A31-AD1A7E7E0021Q36373170-2717DE7B-0120-4737-A427-52392C6BE106Q38155480-B1E1E77F-1CEE-49E4-8D65-0CEAF3BD7795Q38161789-7FD1424F-2E3D-409D-9A0B-13839F48DB6EQ38241802-ED8A87E4-9980-4122-88A4-4B90AC336193Q38344903-E2892C25-5042-4EDA-B8DC-C65474FD5A2AQ38541943-A46D45D9-EB67-4CF1-AF99-5B3AFAEA8A5FQ38598375-1D30AF8E-B8E3-463E-9B54-6ABE701C4372Q38780220-97F1A560-0C4A-4271-ACCD-9FC47F32B122Q39043644-DEEB1338-6CEC-4F97-8D2B-07AA5BF513B8Q41311746-04FB1DE4-F316-410B-B934-D530F6D8028AQ41483238-F7EC4909-F079-41C9-BE30-3305CCA75623Q41627077-B7432417-6886-4319-A88F-D03BE82A608AQ46141187-ED0DCB6F-EC0A-47C1-8DC2-8C9374524DA8Q48298552-084FFEE2-B5BF-4EE6-B12E-D8176E9E3D8EQ51423427-36BAC4DF-B1F1-4236-9D66-986E471DEF7E
P2860
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
What's to like about the prion ...... ynuclein in Parkinson disease?
@en
type
label
What's to like about the prion ...... ynuclein in Parkinson disease?
@en
prefLabel
What's to like about the prion ...... ynuclein in Parkinson disease?
@en
P2860
P921
P356
P1433
P1476
What's to like about the prion ...... ynuclein in Parkinson disease?
@en
P2093
Christopher J R Dunning
Sonia George
P2860
P356
10.4161/PRI.23806
P5008
P577
2013-01-01T00:00:00Z